About 20% of men diagnosed with low testosterone in their 40s and 50s have undiagnosed obstructive sleep apnea (OSA) driving the problem. Closer to 30–40% among men with low testosterone and significant central obesity.

Most testosterone clinics don't ask. The patient gets put on TRT. Symptoms improve modestly. The sleep apnea — which was the upstream cause of the low T in the first place — quietly continues, and in some patients gets worse on TRT.

Here's the bidirectional biology, how to screen yourself, and the clinical sequence that gets it right.

Why OSA suppresses testosterone.

Obstructive sleep apnea repeatedly interrupts deep sleep — the slow-wave and REM phases when most of your nightly testosterone production happens. Chronic fragmentation of these phases produces:

  • Reduced nocturnal testosterone production. Most of your daily testosterone is made during sleep; interrupted sleep means lower morning T.
  • Sympathetic nervous system activation. Chronic stress response from repeated micro-arousals suppresses gonadal function.
  • Increased cortisol. Cortisol and testosterone share precursors and operate in an inverse relationship.
  • Increased aromatization. Inflammation from OSA increases conversion of testosterone to estradiol in adipose tissue, lowering free T further.
  • Reduced insulin sensitivity. OSA drives metabolic dysfunction, and poor metabolic health independently suppresses testosterone.

The net effect: a patient with significant untreated OSA may have total T in the 250–400 ng/dL range as a secondary effect of the sleep dysfunction. Their gonads work fine. The pituitary signal is fine. The bedroom is the problem.

Why TRT can make OSA worse.

Testosterone increases the production of red blood cells (raising hematocrit), which thickens the blood. In a patient with marginally compensated OSA, the increased oxygen demand and the slightly higher resistance to airway flow can push them from "borderline" to "clinically significant" OSA.

Testosterone also has a small direct effect on upper airway muscle tone — typically mild, but in susceptible patients another contributor.

Net effect: a patient with mild undiagnosed OSA who starts TRT may experience worsening sleep architecture, more morning fatigue, snoring increases, and higher hematocrit on lab follow-up. The diagnosis of OSA often only happens at that point — too late to have caught the upstream issue from the start.

The clean clinical sequence
For any man starting TRT with significant snoring, observed apneas, daytime fatigue out of proportion to obvious cause, or BMI over 30 — screen for OSA before starting testosterone. Treating the OSA first often raises baseline testosterone meaningfully, and the TRT decision becomes much cleaner.

The screening tool every TRT consult should include.

The STOP-BANG questionnaire is the standard fast screen for OSA. Each "yes" is one point:

  • Snoring loud enough to be heard through a closed door?
  • Tired or fatigued during the day?
  • Observed apneas (anyone watched you stop breathing in sleep)?
  • Pressure (high blood pressure)?
  • BMI over 35?
  • Age over 50?
  • Neck circumference over 17 inches (men) / 16 inches (women)?
  • Gender male?

Score interpretation:

  • 0–2: low risk
  • 3–4: intermediate risk — sleep study reasonable before high-risk interventions
  • 5–8: high risk — sleep study strongly indicated before TRT

A man with a STOP-BANG of 6 walking into a TRT clinic with total testosterone of 320 should leave with a sleep study referral, not a testosterone prescription.

What the sleep study answers.

An overnight sleep study (in-lab polysomnography or a home sleep apnea test) measures the apnea-hypopnea index (AHI) — how many breathing interruptions per hour of sleep.

  • AHI under 5: normal
  • AHI 5–15: mild OSA
  • AHI 15–30: moderate OSA
  • AHI over 30: severe OSA

A patient with moderate or severe OSA who hasn't been treated for it is rarely a clean TRT candidate. Treat the airway first.

What happens when OSA is treated.

CPAP therapy (continuous positive airway pressure) is the standard treatment. Used consistently for 6+ hours per night, CPAP typically produces:

  • Significant improvement in sleep architecture within 2–4 weeks
  • Measurable testosterone increase by month 3 — often 100–200 ng/dL of total T improvement in patients whose low T was OSA-driven
  • Improved insulin sensitivity, lower cortisol, better mood and energy
  • Reduced cardiovascular risk

After 3 months of consistent CPAP use, a repeat morning testosterone level often clarifies whether TRT is still warranted. For some patients, treating the OSA resolves the low T entirely. For others, it raises baseline T but not to a level that addresses symptoms — and TRT layered on top of a treated airway is the right answer.

When TRT is reasonable despite OSA.

Cases where it's appropriate to proceed with TRT in a patient with OSA:

  • OSA is treated with documented CPAP compliance (or successful surgical/dental intervention).
  • OSA is mild and the patient understands the relationship and accepts monitoring.
  • The patient's hypogonadism is primary (LH and FSH elevated) rather than secondary — meaning OSA isn't the cause.

In all these cases, hematocrit monitoring is essential. We'd recheck CBC at 8 weeks and quarterly thereafter, and adjust dose or modify protocol if hematocrit climbs above 52%.

What this looks like in practice.

Patient profile that should ring this alarm bell:

  • Man 35–60 with body composition trending heavier over the last 5 years
  • Snores loudly, partner reports occasional witnessed apneas
  • Daytime fatigue, low libido, weight gain, brain fog
  • Total testosterone in the 300–450 range
  • BMI 28–35
  • Blood pressure marginally elevated

This patient is often handed a testosterone prescription. He should first be handed a sleep study referral. Treating the OSA may resolve most of the symptoms and produce a testosterone level that doesn't require replacement.

The bottom line.

Low testosterone and sleep apnea exist in a bidirectional relationship that's underdiagnosed in standard TRT workups. A real TRT consult includes OSA screening; a real OSA workup considers the role of sleep on testosterone production.

If you're a candidate for TRT and you snore, are fatigued, or have any of the STOP-BANG risk factors — the cleanest sequence is to screen the airway first. The treatment outcomes for both conditions are dramatically better when addressed in the right order.

Pair this with TRT vs. enclomiphene, morning testosterone testing, and estradiol on TRT for the broader TRT workup picture.

The low-T diagnosis that gets missed most often isn't a low-T problem. It's a sleep problem causing a low-T result. Fix the airway, recheck the numbers, then decide.

Sources: STOP-BANG questionnaire validation in OSA screening; systematic review on OSA and testosterone; CPAP and testosterone restoration trials.

Get the full workup

Testosterone therapy, tuned to your numbers.

DirectCare AI screens for the bidirectional issues — sleep apnea, thyroid, prolactin — that drive low testosterone, so your protocol addresses the actual root cause, not just the headline number.

Start your TRT consult →

Editorial disclosure: This article is for informational purposes only and does not constitute medical advice. All treatments at DirectCare AI are prescribed by US-licensed clinicians based on individual medical evaluation. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Always consult a US-licensed clinician before starting or changing any therapy.